Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Functional Protein

Recombinant Human BTN3A2 Protein, C-His (Active)

Catalog #:   AHF67301 Specific References (49) DATASHEET
Applications: Bioactivity, ELISA, Immunogen, SDS-PAGE, WB
Expression system: Mammalian Cells
Accession: P78410
Protein length: Gln30-Trp248
Overview

Catalog No.

AHF67301

Biological activity

Measured by its ability to enhance anti-CD3-induced IFN gamma secretion of mouse CD3+ T cells. The ED50 for this effect is 0.5-2.5 μg/mL.

Expression system

Mammalian Cells

Species

Homo sapiens (Human)

Protein length

Gln30-Trp248

Nature

Recombinant

Endotoxin level

<0.1 EU/μg of the protein by the LAL method.

Purity

>90% as determined by SDS-PAGE.

Accession

P78410

Applications

Bioactivity, ELISA, Immunogen, SDS-PAGE, WB

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 5% Trehalose, 5% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

BTF4, BT3.2, BTF3, BTN3A2, Butyrophilin subfamily 3 member A2

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Human BTN3A2 protein
References

Genome-wide Mendelian randomization study identifies therapeutic targets for diabetic microangiopathy., PMID:40349847

Identifying novel protein biomarkers with cross-psychiatric disorders effects and potential intervention targets: Evidence from proteomic-Mendelian randomization., PMID:40334965

Identifying Immune Response Protein Biomarkers in Parkinson's-Related Cognitive Impairment and Depression., PMID:40332667

BTN3A2 interacted with MFGE8 to alleviate preeclampsia by promoting ferroptosis and inhibiting angiogenesis., PMID:40147528

Chronic inflammation response as a key factor in polycystic ovary syndrome among patients with bipolar disorder., PMID:39988136

Integrative Multi-omics Analysis and Mendelian Randomization Reveal Potential Therapeutic Targets and their Stratification in Lung Squamous Cell Carcinoma., PMID:39936431

Identification and validation of depression-associated genetic variants in the UK Biobank cohort with transcriptome and DNA methylation analyses in independent cohorts., PMID:39897774

Genome-wide Mendelian randomization mapping the influence of plasma proteome on major depressive disorder., PMID:39892755

Plasma proteomics identifies proteins and pathways associated with incident depression in 46,165 adults., PMID:39424455

Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2., PMID:39142074

Genome-Wide Mendelian Randomization Study Reveals Druggable Genes for Cerebral Small Vessel Disease., PMID:39114924

A Ménage à trois: NLRC5, immunity, and metabolism., PMID:39035010

Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome., PMID:38898508

Unsynchronized butyrophilin molecules dictate cancer cell evasion of Vγ9Vδ2 T-cell killing., PMID:38374404

A distinct topology of BTN3A IgV and B30.2 domains controlled by juxtamembrane regions favors optimal human γδ T cell phosphoantigen sensing., PMID:37993425

Identifying potential risk genes and pathways for neuropsychiatric and substance use disorders using intermediate molecular mediator information., PMID:37415601

Significance of an altered lncRNA landscape in schizophrenia and cognition: clues from a case-control association study., PMID:37009928

Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis., PMID:36911710

Division of labor and cooperation between different butyrophilin proteins controls phosphoantigen-mediated activation of human γδ T cells., PMID:36824912

Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantation., PMID:36655501

Long noncoding RNA profiling reveals that LncRNA BTN3A2 inhibits the host inflammatory response to Eimeria tenella infection in chickens., PMID:36091044

Analysis and Experimental Validation of Rheumatoid Arthritis Innate Immunity Gene CYFIP2 and Pan-Cancer., PMID:35898498

BTN3A2 Expression Is Connected With Favorable Prognosis and High Infiltrating Immune in Lung Adenocarcinoma., PMID:35873496

Multi-omics analysis of the expression and prognostic value of the butyrophilins in breast cancer., PMID:34411352

BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells., PMID:34260935

Prognostic and Therapeutic Significance of BTN3A Proteins in Tumors., PMID:34149914

High Abundance of Intratumoral γδ T Cells Favors a Better Prognosis in Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis., PMID:33101298

Neonatal genetics of gene expression reveal potential origins of autoimmune and allergic disease risk., PMID:32724101

BTN3A2 serves as a prognostic marker and favors immune infiltration in triple-negative breast cancer., PMID:31692043

Metabolites downstream of predicted loss-of-function variants inform relationship to disease., PMID:31679996

Analysis of macaque BTN3A genes and transcripts in the extended MHC: conserved orthologs of human γδ T cell modulators., PMID:31384962

Critical Roles for Coiled-Coil Dimers of Butyrophilin 3A1 in the Sensing of Prenyl Pyrophosphates by Human Vγ2Vδ2 T Cells., PMID:31227581

Identification of the primate-specific gene BTN3A2 as an additional schizophrenia risk gene in the MHC loci., PMID:31133542

Type 1 Diabetes Mellitus-Associated Genetic Variants Contribute to Overlapping Immune Regulatory Networks., PMID:30524468

Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology., PMID:29339503

Expression QTL analysis of glaucoma endophenotypes in the Norfolk Island isolate provides evidence that immune-related genes are associated with optic disc size., PMID:29215094

CpG-specific methylation at rheumatoid arthritis diagnosis as a marker of treatment response., PMID:28447857

MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer., PMID:28409241

Evolutionary and polymorphism analyses reveal the central role of BTN3A2 in the concerted evolution of the BTN3 gene family., PMID:28382515

Exome Array Analysis Identifies Variants in SPOCD1 and BTN3A2 That Affect Risk for Gastric Cancer., PMID:28246015

Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection., PMID:25928882

Activation of human γδ T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin., PMID:25637025

Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells., PMID:23833237

Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure., PMID:22966150

The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodies., PMID:22846996

BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis., PMID:22685580

Differential role for CD277 as a co-regulator of the immune signal in T and NK cells., PMID:21918970

Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex., PMID:19295542

A proteomic approach to evaluate the butyrophilin gene family expression in human milk fat globule membrane., PMID:12124930

Datasheet
$ 360
Product specifications
50 μg 360 100 μg 580

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human BTN3A2 Protein, C-His (Active) [AHF67301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only